PreprintCited by 2Wnt/β-catenin signaling in development and cancerCell Adhesion Molecules ResearchBarrier Structure and Function Studies

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The co-receptor Tetraspanin12 directly captures Norrin to promote ligand-specific β-catenin signaling

Open access

Preprint — published as 10.7554/elife.96743 · Paper page

Abstract

Wnt/β-catenin signaling directs animal development and tissue renewal in a tightly controlled, cell- and tissue- specific manner. In the mammalian central nervous system, the atypical ligand Norrin controls angiogenesis and maintenance of the blood-brain barrier and blood-retina barrier through the Wnt/β-catenin pathway. Like Wnt, Norrin activates signaling by binding and heterodimerizing the receptors Frizzled (Fzd) and Low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6), leading to membrane recruitment of the intracellular transducer Dishevelled (Dvl) and ultimately stabilizing the transcriptional coactivator β-catenin. Unlike Wnt, the cystine-knot ligand Norrin only signals through Fzd4 and additionally requires the co-receptor Tetraspanin12 (Tspan12); however, the mechanism underlying Tspan12-mediated signal enhancement is unclear. It has been proposed that Tspan12 integrates into the Norrin-Fzd4 complex to enhance Norrin-Fzd4 affinity or otherwise allosterically modulate Fzd4 signaling. Here, we measure direct, high-affinity binding between purified Norrin and Tspan12 in a lipid environment and use AlphaFold models to interrogate this interaction interface. We find that Tspan12 and Fzd4 can simultaneously bind Norrin and that a pre-formed Tspan12/Fzd4 heterodimer, as well as cells co-expressing Tspan12 and Fzd4, more efficiently capture low concentrations of Norrin than Fzd4 alone. We also show that Tspan12 competes with both heparan sulfate proteoglycans and LRP6 for Norrin binding and that Tspan12 does not impact Fzd4-Dvl affinity in the presence or absence of Norrin. Our findings suggest that Tspan12 does not allosterically enhance Fzd4 binding to Norrin or Dvl, but instead functions to directly capture Norrin upstream of signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2024.02.03.578714

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 100

  1. 10.1016/j.devcel.2011.09.003 · DOI
  2. 10.1016/j.celrep.2022.110902 · DOI
  3. 10.1242/dev.128.1.87 · DOI
  4. 10.1073/pnas.1805901115 · DOI
  5. 10.1021/nl025623k · DOI
  6. 10.1074/jbc.272.5.2595 · DOI
  7. 10.1074/jbc.M109.092130 · DOI
  8. 10.1016/j.jbc.2022.101628 · DOI
  9. 10.1038/nbt1044 · DOI
  10. 10.1242/jcs.140871 · DOI
  11. 10.7554/eLife.06554 · DOI
  12. 10.15252/emmm.202113977 · DOI
  13. 10.1016/j.neuron.2017.07.031 · DOI
  14. 10.7554/eLife.47300 · DOI
  15. 10.1016/j.yrtph.2016.08.010 · DOI
  16. 10.1016/S0960-9822(03)00370-1 · DOI
  17. 10.1101/cshperspect.a015081 · DOI · Paper page
  18. 10.1021/jacs.7b10680 · DOI
  19. 10.1007/s10549-020-05817-w · DOI
  20. 10.1074/jbc.M114.612648 · DOI
  21. 10.1038/s41467-023-37689-1 · DOI
  22. 10.1371/journal.pcbi.1005659 · DOI · Paper page
  23. 10.1126/sciadv.add3677 · DOI
  24. 10.1126/science.aat1178 · DOI
  25. 10.1101/2021.10.04.463034 · DOI · Paper page
  26. 10.1002/pro.3235 · DOI · Paper page
  27. 10.1038/nsmb.3016 · DOI · Paper page
  28. 10.1101/cshperspect.a022103 · DOI
  29. 10.1101/2021.05.29.446300 · DOI
  30. 10.1038/nature22306 · DOI · Paper page
  31. 10.1086/425080 · DOI
  32. 10.1016/j.cell.2009.07.048 · DOI
  33. 10.1101/gad.228544.113 · DOI
  34. 10.1007/s00018-013-1444-8 · DOI
  35. 10.1002/pro.519 · DOI
  36. 10.1016/j.celrep.2017.06.004 · DOI
  37. 10.1016/j.ccr.2012.03.040 · DOI
  38. 10.1002/hep.30646 · DOI
  39. 10.1016/j.cell.2023.06.026 · DOI
  40. 10.1016/0092-8674(93)90368-Z · DOI
  41. 10.1073/pnas.1910547117 · DOI
  42. 10.1126/scisignal.abo2820 · DOI
  43. 10.1016/j.immuni.2012.11.019 · DOI
  44. 10.1038/s41592-022-01488-1 · DOI · Paper page
  45. 10.1242/dev.200312 · DOI
  46. 2022, SZN-413, a monospecific Fzd4 Agonist as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy, Invest Ophthalmol Vis Sci, 63, 668
  47. 10.1002/humu.21250 · DOI
  48. 10.1016/j.cell.2017.05.016 · DOI · Paper page
  49. 10.1016/0092-8674(92)90630-U · DOI
  50. 10.1016/j.tips.2023.03.008 · DOI
  51. 10.1073/pnas.1412062112 · DOI
  52. 10.1126/science.1160741 · DOI
  53. 10.1016/j.ajhg.2017.05.001 · DOI
  54. 10.1038/nprot.2014.039 · DOI
  55. 10.1016/j.ccell.2016.03.002 · DOI
  56. 10.1371/journal.pone.0004046 · DOI
  57. 10.1016/j.ajhg.2010.01.012 · DOI
  58. 10.1016/j.yexcr.2006.01.032 · DOI
  59. 10.1083/jcb.135.3.819 · DOI
  60. 10.1146/annurev-biochem-040320-103615 · DOI
  61. 10.1016/S0076-6879(09)64011-8 · DOI
  62. 10.1038/ng957 · DOI
  63. 10.1016/j.ejphar.2015.05.031 · DOI
  64. 10.1242/jcs.002956 · DOI
  65. 10.1001/archopht.1997.01100150653015 · DOI
  66. 10.1038/cr.2015.92 · DOI
  67. 10.1074/jbc.M609618200 · DOI
  68. 10.1002/jcb.10140 · DOI
  69. 10.1101/cshperspect.a007898 · DOI · Paper page
  70. 10.1038/s41467-023-38390-z · DOI
  71. 10.1016/j.gep.2008.01.007 · DOI
  72. 10.1016/j.tcb.2023.09.003 · DOI
  73. 10.1126/science.abd9836 · DOI
  74. 10.1093/oncolo/oyad007 · DOI
  75. 10.1073/pnas.1114802109 · DOI
  76. 10.1038/s41592-023-02087-4 · DOI · Paper page
  77. 10.1086/383202 · DOI
  78. 10.1073/pnas.2218238120 · DOI · Paper page
  79. 10.1038/s41467-020-15459-7 · DOI
  80. 10.1016/j.celrep.2018.09.045 · DOI
  81. 10.1042/BST20160284 · DOI
  82. 10.7554/eLife.06489 · DOI
  83. 10.1096/fj.201700144R · DOI
  84. 10.1073/pnas.1813217115 · DOI
  85. 10.1016/j.cell.2012.10.042 · DOI · Paper page
  86. 10.1016/0014-5793(95)00062-E · DOI
  87. 10.1073/pnas.0611448104 · DOI
  88. 10.1016/S0092-8674(04)00216-8 · DOI · Paper page
  89. 10.1101/2023.05.29.542358 · DOI
  90. 10.1016/S0960-9822(02)70716-1 · DOI
  91. 10.15252/embj.2020105246 · DOI
  92. 10.1091/mbc.9.10.2751 · DOI
  93. 10.1042/bj3510629 · DOI
  94. 10.1016/j.cell.2009.07.047 · DOI
  95. 10.1242/dev.013540 · DOI · Paper page
  96. 10.1038/ncomms16050 · DOI
  97. 10.1074/jbc.M102156200 · DOI
  98. 10.1016/j.devcel.2014.08.018 · DOI · Paper page
  99. 10.1016/j.cell.2016.09.056 · DOI
  100. 10.1038/srep12201 · DOI

Metadata

Authors
Bruguera, E. S., Mahoney, J. P., & Weis, W. I.
Affiliations
Stanford Medicine (US)
Corresponding author
Bruguera, Elise S.
Venue
eLife
Publisher
openRxiv
Published
2024-02-03
Volume
13
ISSN
2050-084X (ISSN-L)
OpenAlex
W4405987333
Cited by
2
References
1
Citations by year
2026: 2
FWCI
0.59
Type
journal article
Language
en
Open access
Locations
  • eLife (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
Funders
  • National Institutes of Health
  • National Eye Institute (F31EY031947)
  • National Institute of General Medical Sciences (R35GM131747, F32GM126642)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
Norrin, Wnt/β-catenin signaling, FZD4, Frizzled receptors, co-receptors, heparan sulfate proteoglycans, LRP6, Dishevelled, angiogenesis, blood-brain barrier, blood-retinal barrier, central nervous system development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review